Literature DB >> 26210522

Epidemiology of new-onset paroxysmal atrial fibrillation in the General Intensive Care Unit population and after discharge from ICU. A retrospective epidemiological study.

Leonid Koyfman, Evgeni Brotfain1, Ruslan Kutz, Amit Frenkel, Andrei Schwartz, Avi Boniel, Alexander Zlotnik, Moti Klein.   

Abstract

BACKGROUND: Evidence of various cardiac arrhythmias in septic patients has been demonstrated by multiple clinical reports and observations. Most cardiac arrhythmias in sepsis are new-onset and may be related to sepsis-induced myocardial dysfunction. We propose to investigate and analyze data of new-onset paroxysmal atrial fibrillation (AF) in a critically ill septic population.
METHODS: This is a retrospective epidemiologic study. We collected clinical data from two hundred septic patients who developed a new episode of atrial fibrillation during their hospitalization in General Intensive Care Unit (GICU) between January 2007 and June 2013.
RESULTS: Of these 200 septic patients, 81 septic patients developed a new episode of AF and included in the present study. Thirty-seven patients had no past medical history of atrial fibrillation (AF) or antiarrhythmic therapy (new episode of atrial fibrillation, Group 1) and 44 had previously known episodes of atrial fibrillation and were prescribed antiarrhythmic therapy at home (Group 2). Group 2 patients had longer duration of recurrent episodes of atrial fibrillation compared to patients in Group 1 (11.07 ± 8.7 vs. 7.4 ± 6.1 days; P = 0.013). The overall ICU and in-hospital mortality rate was similar in both study groups. There was no significant difference in new stroke and pulmonary embolism (PE) between both study groups (P > 0.05).
CONCLUSION: In the present study we demonstrated no difference in morbidity and mortality rate in-ICU and after discharge between septic patients who had previous AF episodes and patients who had no previous past medical history of any cardiac arrhythmias.

Entities:  

Keywords:  New-onset atrial fibrillation; cardiac arrhythmias; sepsis

Mesh:

Year:  2015        PMID: 26210522     DOI: 10.5603/AIT.a2015.0040

Source DB:  PubMed          Journal:  Anaesthesiol Intensive Ther        ISSN: 1642-5758


  7 in total

Review 1.  New-onset atrial fibrillation in adult critically ill patients: a scoping review.

Authors:  Mik Wetterslev; Nicolai Haase; Christian Hassager; Emilie P Belley-Cote; William F McIntyre; Youzhong An; Jiawei Shen; Alexandre Biasi Cavalcanti; Fernando G Zampieri; Helio Penna Guimaraes; Anders Granholm; Anders Perner; Morten Hylander Møller
Journal:  Intensive Care Med       Date:  2019-05-14       Impact factor: 17.440

Review 2.  Stroke Prevention for Patients with Atrial Fibrillation: Beyond the Guidelines.

Authors:  William F McIntyre; Jeff Healey
Journal:  J Atr Fibrillation       Date:  2017-04-30

Review 3.  Prevalence of New-Onset Atrial Fibrillation and Associated Outcomes in Patients with Sepsis: A Systematic Review and Meta-Analysis.

Authors:  Bernadette Corica; Giulio Francesco Romiti; Stefania Basili; Marco Proietti
Journal:  J Pers Med       Date:  2022-03-30

Review 4.  Cardiac Arrhythmias in a Septic ICU Population: A Review.

Authors:  Andrei Schwartz; Evgeni Brotfain; Leonid Koyfman; Moti Klein
Journal:  J Crit Care Med (Targu Mures)       Date:  2015-11-10

5.  Clinical prediction scores and early anticoagulation therapy for new-onset atrial fibrillation in critical illness: a post-hoc analysis.

Authors:  Masaaki Sakuraya; Takuo Yoshida; Yusuke Sasabuchi; Shodai Yoshihiro; Shigehiko Uchino
Journal:  BMC Cardiovasc Disord       Date:  2021-09-08       Impact factor: 2.298

Review 6.  Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology.

Authors:  Dobromir Dobrev; Stanley Nattel; Jordi Heijman; Roddy Hiram; Na Li
Journal:  Nat Rev Cardiol       Date:  2022-09-15       Impact factor: 49.421

7.  Landiolol for managing atrial fibrillation in intensive care.

Authors:  Sebastian Rehberg; Michael Joannidis; Tony Whitehouse; Andrea Morelli
Journal:  Eur Heart J Suppl       Date:  2018-01-08       Impact factor: 1.803

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.